INFINIUMPharmaceuticals
Infinium Pharmachem Ltd — Cash Flow Statement
₹192.80
-0.37%
Infinium Pharmachem Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -37.81 Cr | 1.41 Cr | 1.12 Cr | 7.07 Cr | — |
| Repurchase Of Capital Stock | -1.61 Cr | -0.30 Cr | — | — | — |
| Issuance Of Capital Stock | 41.10 Cr | 25.26 Cr | 0.00 | 0.00 | — |
| Capital Expenditure | -8.65 Cr | -3.51 Cr | -7.47 Cr | -4.73 Cr | — |
| End Cash Position | 34.84 Cr | 11.91 Cr | 5.98 Cr | 5.45 Cr | — |
| Other Cash Adjustment Outside Changein Cash | 1000.00 | 2000.00 | 1000.00 | — | 1000.00 |
| Beginning Cash Position | 11.91 Cr | 5.98 Cr | 5.45 Cr | 1.99 Cr | — |
| Changes In Cash | 22.93 Cr | 5.93 Cr | 0.53 Cr | 3.46 Cr | — |
| Financing Cash Flow | 79.29 Cr | 4.81 Cr | -3.10 Cr | -1.70 Cr | — |
| Net Other Financing Charges | 43.47 Cr | -18.00 Cr | — | — | — |
| Interest Paid Cff | -3.67 Cr | -2.16 Cr | -3.10 Cr | -1.70 Cr | — |
| Net Common Stock Issuance | 39.49 Cr | 24.96 Cr | 0.00 | 0.00 | — |
| Common Stock Payments | -1.61 Cr | -0.30 Cr | — | — | — |
| Common Stock Issuance | 41.10 Cr | 25.26 Cr | 0.00 | 0.00 | — |
| Investing Cash Flow | -27.21 Cr | -3.79 Cr | -4.96 Cr | -6.63 Cr | — |
| Net Other Investing Changes | -3.41 Cr | -0.29 Cr | 2.32 Cr | -2.45 Cr | — |
| Interest Received Cfi | 0.10 Cr | -0.18 Cr | -0.02 Cr | -0.03 Cr | — |
| Net Investment Purchase And Sale | -29.02 Cr | 0.00 | — | — | — |
| Net Business Purchase And Sale | 13.88 Cr | 0.23 Cr | 0.40 Cr | 0.63 Cr | — |
| Net Intangibles Purchase And Sale | -3.39 Cr | 0.00 | 0.00 | 0.00 | — |
| Purchase Of Intangibles | -3.39 Cr | 0.00 | 0.00 | 0.00 | — |
| Net PPE Purchase And Sale | -5.25 Cr | -3.51 Cr | -7.47 Cr | -4.73 Cr | — |
| Purchase Of PPE | -5.25 Cr | -3.51 Cr | -7.47 Cr | -4.73 Cr | — |
| Operating Cash Flow | -29.16 Cr | 4.92 Cr | 8.59 Cr | 11.80 Cr | — |
| Taxes Refund Paid | -3.86 Cr | -3.67 Cr | -3.12 Cr | -1.96 Cr | — |
| Interest Received Cfo | -0.10 Cr | 0.18 Cr | 0.02 Cr | — | — |
| Change In Working Capital | -44.21 Cr | -11.38 Cr | -5.27 Cr | 3.36 Cr | — |
| Change In Other Current Liabilities | -0.89 Cr | -1.95 Cr | 6.43 Cr | 16.39 Cr | — |
| Change In Other Current Assets | -16.69 Cr | 1.07 Cr | -1.84 Cr | -0.92 Cr | — |
| Change In Payable | 7.87 Cr | -2.31 Cr | -4.99 Cr | -0.06 Cr | — |
| Change In Inventory | -19.56 Cr | -4.98 Cr | -3.36 Cr | -6.98 Cr | — |
| Change In Receivables | -15.73 Cr | -3.86 Cr | -1.83 Cr | -6.85 Cr | — |
| Other Non Cash Items | 3.67 Cr | 2.16 Cr | 3.10 Cr | 1.73 Cr | — |
| Depreciation And Amortization | 3.29 Cr | 2.67 Cr | 1.34 Cr | 0.63 Cr | — |
| Depreciation | 3.29 Cr | 2.67 Cr | 1.34 Cr | 0.63 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 0.18 Cr | -0.05 Cr | -0.03 Cr | -0.03 Cr | — |
| Net Income From Continuing Operations | 11.57 Cr | 15.21 Cr | 12.95 Cr | 8.63 Cr | — |
| Sale Of Business | — | 0.23 Cr | 0.40 Cr | 0.63 Cr | 0.10 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Infinium Pharmachem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.